← SynDRA
exenatide
SynDRA canonical compound SYN0041852 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | GCG | GLP1R | INS |
|---|
| Mechanism of action | GLP receptor agonist |
|---|
| Indication | diabetes mellitus |
|---|
| Disease area | endocrinology |
|---|
All known targets
Mechanisms of action (all sources)
- GLP1R AGONIST
- Glucagon-like peptide 1 receptor agonist
- GLP1R FULL AGONIST
- GLP receptor agonist
- GLP1R BINDER
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALB
- APP
- GCGR
- GIPR
- GPR146
- NPY1R
- NPY2R
Drug classes
- Glucagon-like Peptide-1 (GLP-1) Agonists
- Anti-Obesity Agents
- Hormones
- Hypoglycemic Agents
- Incretins
- GLP-1 Receptor Agonist
- Glucagon-Like Peptide-1 Receptor Agonists
ATC classes
- A10B · BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Cross-references
Synonyms
- BYDUREON
- BYDUREON BCISE
- BYDUREON PEN
- BYETTA
- Bydureon
- Byetta
- EXENATIDE SYNTHETIC
- byetta
- exenatide synthetic
- bydureon
- exendin-4
- AC002993
- AC2993A
- Exenatide synthetic
- Exenatida
- EXENDIN-4
- AC-2993
- AC-002993
- AC-2993A
- AC-2993LAR
- AC2993
- DA-3091
- ITCA-650
- LY-2148568
- LY2148568
- Bydureon bcise
- Bydureon pen
- Exenatide Synthetic
- AC 2993 LAR
- Ex4 peptide
- Byetta (TN)
- Exendin 4 (Heloderma suspectum)
- Extendin-4
- L-Serinamide
- LY 2148568
- exenatide (usp-rs)
- Exendin 4
- exenatide (usp monograph)
Look up exenatide in the interactive SynDRA portal →